OBJECTIVE: The MoCA is a new screening test to detect Mild Cognitive Impairment (MCI). Purpose of this study is validating the Dutch version (MoCA-D). METHOD: We administered the MoCA-D to healthy control subjects and to elderly with MCI or dementia from a memory disorder outpatient clinic and a geriatric (outpatient) clinic (n = 30, 32, 37 respectively, age > or = 60). Neuropsychological testing was part of the standard procedure for patients to diagnose MCI. Sensitivity, specificity and predictive values (positive: PPV and negative: NPV) of the MoCA-D were assessed. RESULTS: A significant effect of group was found on MoCA-D total score (F (2.95) =67.9; p < 0.01). With a cutoff score of < or = 25, sensitivity and specificity to detect MCI in relation to healthy controls were 72% and 73%, respectively. PPV and NPV were 84% and 56%, respectively. With a cut-off score of < or = 20, sensitivity to detect dementia in relation to MCI was 100% for severe dementia and 75% for mild dementia. Specificity for dementia was 81%, PPV 94% and NPV 55%. CONCLUSION: The MoCA-D distinguishes between healthy elderly, MCI patients and dementia patients. However, in this study, insufficient sensitivity and poor specificity were found. For the present, applying a broader and flexible screening procedure in order to detect MCI seems a more useful method than the interpretation of one test result in particular.
OBJECTIVE: The MoCA is a new screening test to detect Mild Cognitive Impairment (MCI). Purpose of this study is validating the Dutch version (MoCA-D). METHOD: We administered the MoCA-D to healthy control subjects and to elderly with MCI or dementia from a memory disorderoutpatient clinic and a geriatric (outpatient) clinic (n = 30, 32, 37 respectively, age > or = 60). Neuropsychological testing was part of the standard procedure for patients to diagnose MCI. Sensitivity, specificity and predictive values (positive: PPV and negative: NPV) of the MoCA-D were assessed. RESULTS: A significant effect of group was found on MoCA-D total score (F (2.95) =67.9; p < 0.01). With a cutoff score of < or = 25, sensitivity and specificity to detect MCI in relation to healthy controls were 72% and 73%, respectively. PPV and NPV were 84% and 56%, respectively. With a cut-off score of < or = 20, sensitivity to detect dementia in relation to MCI was 100% for severe dementia and 75% for mild dementia. Specificity for dementia was 81%, PPV 94% and NPV 55%. CONCLUSION: The MoCA-D distinguishes between healthy elderly, MCI patients and dementiapatients. However, in this study, insufficient sensitivity and poor specificity were found. For the present, applying a broader and flexible screening procedure in order to detect MCI seems a more useful method than the interpretation of one test result in particular.
Authors: Daniel H J Davis; Sam T Creavin; Jennifer L Y Yip; Anna H Noel-Storr; Carol Brayne; Sarah Cullum Journal: Cochrane Database Syst Rev Date: 2015-10-29
Authors: Steven Bunt; Rónán O'Caoimh; Wim P Krijnen; D William Molloy; Geert Pieter Goodijk; Cees P van der Schans; Hans J S M Hobbelen Journal: BMC Geriatr Date: 2015-10-02 Impact factor: 3.921
Authors: Viviana Mendoza Ramos; Charlotte Paulyn; Leen Van den Steen; Maria E Hernandez-Diaz Huici; Marc De Bodt; Gwen Van Nuffelen Journal: Int J Lang Commun Disord Date: 2021-01-23 Impact factor: 3.020
Authors: Joey P A J Verdijk; Julia C M Pottkämper; Esmée Verwijk; Guido A van Wingen; Michel J A M van Putten; Jeannette Hofmeijer; Jeroen A van Waarde Journal: Trials Date: 2022-04-18 Impact factor: 2.728
Authors: Daniel Hj Davis; Samuel T Creavin; Jennifer Ly Yip; Anna H Noel-Storr; Carol Brayne; Sarah Cullum Journal: Cochrane Database Syst Rev Date: 2021-07-13